Guno צְבִי
We fight, We win
The BioCubaFarma group is currently carrying out 102 projects, of which 75 have a Cuban patent, explained Rolando Pérez, director of Science and Innovation of this state conglomerate dedicated to the production of medicines, medical equipment and high-tech services.
The HerberSavax therapeutic vaccine―one of the leading products in the oncology area―is in phase III clinical trials in ovarian tumors and hepatocarcinoma, which is the most common type of liver cancer.
Developed by the Center for Genetic Engineering and Biotechnology (CIGB), a leading entity in this field on the island, the vaccine reduces the formation of blood vessels in the tumor, thereby limiting the supply of nutrients and oxygen and inhibiting its growth and shows “encouraging results” in some patients.
https://oncubanews.com/en/cuba/cuba-develops-new-drugs-against-cancer-and-other-diseases/
The HerberSavax therapeutic vaccine―one of the leading products in the oncology area―is in phase III clinical trials in ovarian tumors and hepatocarcinoma, which is the most common type of liver cancer.
Developed by the Center for Genetic Engineering and Biotechnology (CIGB), a leading entity in this field on the island, the vaccine reduces the formation of blood vessels in the tumor, thereby limiting the supply of nutrients and oxygen and inhibiting its growth and shows “encouraging results” in some patients.
https://oncubanews.com/en/cuba/cuba-develops-new-drugs-against-cancer-and-other-diseases/